Antineoplastic Activity of the Combination Loratadine–Simvastatin–Gefitinib in HPV-Positive Cervical Cancer Cells: In Vitro and In Vivo Studies
Tania Raya-Bahena, Rene M. Rivera-Escobar, Elisabeth Hernández-Gallegos, Javier E. Jiménez-Salazar, Pablo Damián-Matsumura, Janice García-Quiroz, Javier Camacho · 2026
Read Antineoplastic Activity of the Combination Loratadine–Simvastatin–Gefitinib in HPV-Positive Cervical Cancer Cells: In Vitro and In Vivo Studies by Tania Raya-Bahena, Rene M. Rivera-Escobar, Elisabeth Hernández-Gallegos, Javier E. Jiménez-Salazar, Pablo Damián-Matsumura, Janice García-Quiroz, Javier Camacho (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13511572.txt.
Description
Simple SummaryCervical cancer (CC) is the most clinically significant HPV-associated malignancy, leading to thousands of deaths, especially in developing countries. Although cisplatin-based chemotherapy is the first-line treatment, the development of resistance and severe side effects frequently limits its use. Therefore, identifying safer and more effective therapeutic strategies is urgently needed.
Catalog record
| CREATOR | Tania Raya-Bahena, Rene M. Rivera-Escobar, Elisabeth Hernández-Gallegos, Javier E. Jiménez-Salazar, Pablo Damián-Matsumura, Janice García-Quiroz, Javier Camacho |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 26 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |